Felodipine Sustained-Release Tablet Market
1 Study Coverage
1.1 Felodipine Sustained-Release Tablet Product Introduction
1.2 Market by Type
1.2.1 Global Felodipine Sustained-Release Tablet Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 2.5mg Per Tablet
1.2.3 5mg Per Tablet
1.2.4 Others
1.3 Market by Application
1.3.1 Global Felodipine Sustained-Release Tablet Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Treat High Blood Pressure
1.3.3 Relieve Angina
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Felodipine Sustained-Release Tablet Sales Estimates and Forecasts 2017-2028
2.2 Global Felodipine Sustained-Release Tablet Revenue Estimates and Forecasts 2017-2028
2.3 Global Felodipine Sustained-Release Tablet Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Felodipine Sustained-Release Tablet Sales by Region
2.4.1 Global Felodipine Sustained-Release Tablet Sales by Region (2017-2022)
2.4.2 Global Sales Felodipine Sustained-Release Tablet by Region (2023-2028)
2.5 Global Felodipine Sustained-Release Tablet Revenue by Region
2.5.1 Global Felodipine Sustained-Release Tablet Revenue by Region (2017-2022)
2.5.2 Global Felodipine Sustained-Release Tablet Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Felodipine Sustained-Release Tablet Sales by Manufacturers
3.1.1 Global Top Felodipine Sustained-Release Tablet Manufacturers by Sales (2017-2022)
3.1.2 Global Felodipine Sustained-Release Tablet Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Felodipine Sustained-Release Tablet in 2021
3.2 Global Felodipine Sustained-Release Tablet Revenue by Manufacturers
3.2.1 Global Felodipine Sustained-Release Tablet Revenue by Manufacturers (2017-2022)
3.2.2 Global Felodipine Sustained-Release Tablet Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Felodipine Sustained-Release Tablet Revenue in 2021
3.3 Global Felodipine Sustained-Release Tablet Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Felodipine Sustained-Release Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Felodipine Sustained-Release Tablet Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Felodipine Sustained-Release Tablet Sales by Type
4.1.1 Global Felodipine Sustained-Release Tablet Historical Sales by Type (2017-2022)
4.1.2 Global Felodipine Sustained-Release Tablet Forecasted Sales by Type (2023-2028)
4.1.3 Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2028)
4.2 Global Felodipine Sustained-Release Tablet Revenue by Type
4.2.1 Global Felodipine Sustained-Release Tablet Historical Revenue by Type (2017-2022)
4.2.2 Global Felodipine Sustained-Release Tablet Forecasted Revenue by Type (2023-2028)
4.2.3 Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2017-2028)
4.3 Global Felodipine Sustained-Release Tablet Price by Type
4.3.1 Global Felodipine Sustained-Release Tablet Price by Type (2017-2022)
4.3.2 Global Felodipine Sustained-Release Tablet Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Felodipine Sustained-Release Tablet Sales by Application
5.1.1 Global Felodipine Sustained-Release Tablet Historical Sales by Application (2017-2022)
5.1.2 Global Felodipine Sustained-Release Tablet Forecasted Sales by Application (2023-2028)
5.1.3 Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2028)
5.2 Global Felodipine Sustained-Release Tablet Revenue by Application
5.2.1 Global Felodipine Sustained-Release Tablet Historical Revenue by Application (2017-2022)
5.2.2 Global Felodipine Sustained-Release Tablet Forecasted Revenue by Application (2023-2028)
5.2.3 Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2017-2028)
5.3 Global Felodipine Sustained-Release Tablet Price by Application
5.3.1 Global Felodipine Sustained-Release Tablet Price by Application (2017-2022)
5.3.2 Global Felodipine Sustained-Release Tablet Price Forecast by Application (2023-2028)
6 North America
6.1 North America Felodipine Sustained-Release Tablet Market Size by Type
6.1.1 North America Felodipine Sustained-Release Tablet Sales by Type (2017-2028)
6.1.2 North America Felodipine Sustained-Release Tablet Revenue by Type (2017-2028)
6.2 North America Felodipine Sustained-Release Tablet Market Size by Application
6.2.1 North America Felodipine Sustained-Release Tablet Sales by Application (2017-2028)
6.2.2 North America Felodipine Sustained-Release Tablet Revenue by Application (2017-2028)
6.3 North America Felodipine Sustained-Release Tablet Market Size by Country
6.3.1 North America Felodipine Sustained-Release Tablet Sales by Country (2017-2028)
6.3.2 North America Felodipine Sustained-Release Tablet Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Felodipine Sustained-Release Tablet Market Size by Type
7.1.1 Europe Felodipine Sustained-Release Tablet Sales by Type (2017-2028)
7.1.2 Europe Felodipine Sustained-Release Tablet Revenue by Type (2017-2028)
7.2 Europe Felodipine Sustained-Release Tablet Market Size by Application
7.2.1 Europe Felodipine Sustained-Release Tablet Sales by Application (2017-2028)
7.2.2 Europe Felodipine Sustained-Release Tablet Revenue by Application (2017-2028)
7.3 Europe Felodipine Sustained-Release Tablet Market Size by Country
7.3.1 Europe Felodipine Sustained-Release Tablet Sales by Country (2017-2028)
7.3.2 Europe Felodipine Sustained-Release Tablet Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Felodipine Sustained-Release Tablet Market Size by Type
8.1.1 Asia Pacific Felodipine Sustained-Release Tablet Sales by Type (2017-2028)
8.1.2 Asia Pacific Felodipine Sustained-Release Tablet Revenue by Type (2017-2028)
8.2 Asia Pacific Felodipine Sustained-Release Tablet Market Size by Application
8.2.1 Asia Pacific Felodipine Sustained-Release Tablet Sales by Application (2017-2028)
8.2.2 Asia Pacific Felodipine Sustained-Release Tablet Revenue by Application (2017-2028)
8.3 Asia Pacific Felodipine Sustained-Release Tablet Market Size by Region
8.3.1 Asia Pacific Felodipine Sustained-Release Tablet Sales by Region (2017-2028)
8.3.2 Asia Pacific Felodipine Sustained-Release Tablet Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Felodipine Sustained-Release Tablet Market Size by Type
9.1.1 Latin America Felodipine Sustained-Release Tablet Sales by Type (2017-2028)
9.1.2 Latin America Felodipine Sustained-Release Tablet Revenue by Type (2017-2028)
9.2 Latin America Felodipine Sustained-Release Tablet Market Size by Application
9.2.1 Latin America Felodipine Sustained-Release Tablet Sales by Application (2017-2028)
9.2.2 Latin America Felodipine Sustained-Release Tablet Revenue by Application (2017-2028)
9.3 Latin America Felodipine Sustained-Release Tablet Market Size by Country
9.3.1 Latin America Felodipine Sustained-Release Tablet Sales by Country (2017-2028)
9.3.2 Latin America Felodipine Sustained-Release Tablet Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Felodipine Sustained-Release Tablet Market Size by Type
10.1.1 Middle East and Africa Felodipine Sustained-Release Tablet Sales by Type (2017-2028)
10.1.2 Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Type (2017-2028)
10.2 Middle East and Africa Felodipine Sustained-Release Tablet Market Size by Application
10.2.1 Middle East and Africa Felodipine Sustained-Release Tablet Sales by Application (2017-2028)
10.2.2 Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Application (2017-2028)
10.3 Middle East and Africa Felodipine Sustained-Release Tablet Market Size by Country
10.3.1 Middle East and Africa Felodipine Sustained-Release Tablet Sales by Country (2017-2028)
10.3.2 Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Astrazeneca
11.1.1 Astrazeneca Corporation Information
11.1.2 Astrazeneca Overview
11.1.3 Astrazeneca Felodipine Sustained-Release Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Astrazeneca Felodipine Sustained-Release Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Astrazeneca Recent Developments
11.2 NanJing Easeheal Phaemaecutical
11.2.1 NanJing Easeheal Phaemaecutical Corporation Information
11.2.2 NanJing Easeheal Phaemaecutical Overview
11.2.3 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 NanJing Easeheal Phaemaecutical Recent Developments
11.3 SHANXI KANGBO BIOLOGICAL PRODUCT
11.3.1 SHANXI KANGBO BIOLOGICAL PRODUCT Corporation Information
11.3.2 SHANXI KANGBO BIOLOGICAL PRODUCT Overview
11.3.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 SHANXI KANGBO BIOLOGICAL PRODUCT Recent Developments
11.4 Lifeon
11.4.1 Lifeon Corporation Information
11.4.2 Lifeon Overview
11.4.3 Lifeon Felodipine Sustained-Release Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Lifeon Felodipine Sustained-Release Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lifeon Recent Developments
11.5 Changzhou Siyao Pharmaceutical
11.5.1 Changzhou Siyao Pharmaceutical Corporation Information
11.5.2 Changzhou Siyao Pharmaceutical Overview
11.5.3 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Changzhou Siyao Pharmaceutical Recent Developments
11.6 Mylan
11.6.1 Mylan Corporation Information
11.6.2 Mylan Overview
11.6.3 Mylan Felodipine Sustained-Release Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Mylan Felodipine Sustained-Release Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Mylan Recent Developments
11.7 Sandoz
11.7.1 Sandoz Corporation Information
11.7.2 Sandoz Overview
11.7.3 Sandoz Felodipine Sustained-Release Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sandoz Felodipine Sustained-Release Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sandoz Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Felodipine Sustained-Release Tablet Industry Chain Analysis
12.2 Felodipine Sustained-Release Tablet Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Felodipine Sustained-Release Tablet Production Mode & Process
12.4 Felodipine Sustained-Release Tablet Sales and Marketing
12.4.1 Felodipine Sustained-Release Tablet Sales Channels
12.4.2 Felodipine Sustained-Release Tablet Distributors
12.5 Felodipine Sustained-Release Tablet Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Felodipine Sustained-Release Tablet Industry Trends
13.2 Felodipine Sustained-Release Tablet Market Drivers
13.3 Felodipine Sustained-Release Tablet Market Challenges
13.4 Felodipine Sustained-Release Tablet Market Restraints
14 Key Findings in The Global Felodipine Sustained-Release Tablet Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Felodipine Sustained-Release Tablet Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 2.5mg Per Tablet
Table 3. Major Manufacturers of 5mg Per Tablet
Table 4. Major Manufacturers of Others
Table 5. Global Felodipine Sustained-Release Tablet Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Felodipine Sustained-Release Tablet Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Felodipine Sustained-Release Tablet Sales by Region (2017-2022) & (K Units)
Table 8. Global Felodipine Sustained-Release Tablet Sales Market Share by Region (2017-2022)
Table 9. Global Felodipine Sustained-Release Tablet Sales by Region (2023-2028) & (K Units)
Table 10. Global Felodipine Sustained-Release Tablet Sales Market Share by Region (2023-2028)
Table 11. Global Felodipine Sustained-Release Tablet Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Felodipine Sustained-Release Tablet Revenue Market Share by Region (2017-2022)
Table 13. Global Felodipine Sustained-Release Tablet Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Felodipine Sustained-Release Tablet Revenue Market Share by Region (2023-2028)
Table 15. Global Felodipine Sustained-Release Tablet Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Felodipine Sustained-Release Tablet Sales Share by Manufacturers (2017-2022)
Table 17. Global Felodipine Sustained-Release Tablet Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Felodipine Sustained-Release Tablet Revenue Share by Manufacturers (2017-2022)
Table 19. Felodipine Sustained-Release Tablet Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Felodipine Sustained-Release Tablet Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Felodipine Sustained-Release Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Felodipine Sustained-Release Tablet as of 2021)
Table 22. Felodipine Sustained-Release Tablet Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Felodipine Sustained-Release Tablet Product Offered
Table 24. Date of Manufacturers Enter into Felodipine Sustained-Release Tablet Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)
Table 27. Global Felodipine Sustained-Release Tablet Sales by Type (2023-2028) & (K Units)
Table 28. Global Felodipine Sustained-Release Tablet Sales Share by Type (2017-2022)
Table 29. Global Felodipine Sustained-Release Tablet Sales Share by Type (2023-2028)
Table 30. Global Felodipine Sustained-Release Tablet Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Felodipine Sustained-Release Tablet Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Felodipine Sustained-Release Tablet Revenue Share by Type (2017-2022)
Table 33. Global Felodipine Sustained-Release Tablet Revenue Share by Type (2023-2028)
Table 34. Felodipine Sustained-Release Tablet Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Felodipine Sustained-Release Tablet Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)
Table 37. Global Felodipine Sustained-Release Tablet Sales by Application (2023-2028) & (K Units)
Table 38. Global Felodipine Sustained-Release Tablet Sales Share by Application (2017-2022)
Table 39. Global Felodipine Sustained-Release Tablet Sales Share by Application (2023-2028)
Table 40. Global Felodipine Sustained-Release Tablet Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Felodipine Sustained-Release Tablet Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Felodipine Sustained-Release Tablet Revenue Share by Application (2017-2022)
Table 43. Global Felodipine Sustained-Release Tablet Revenue Share by Application (2023-2028)
Table 44. Felodipine Sustained-Release Tablet Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Felodipine Sustained-Release Tablet Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)
Table 47. North America Felodipine Sustained-Release Tablet Sales by Type (2023-2028) & (K Units)
Table 48. North America Felodipine Sustained-Release Tablet Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Felodipine Sustained-Release Tablet Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)
Table 51. North America Felodipine Sustained-Release Tablet Sales by Application (2023-2028) & (K Units)
Table 52. North America Felodipine Sustained-Release Tablet Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Felodipine Sustained-Release Tablet Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Felodipine Sustained-Release Tablet Sales by Country (2017-2022) & (K Units)
Table 55. North America Felodipine Sustained-Release Tablet Sales by Country (2023-2028) & (K Units)
Table 56. North America Felodipine Sustained-Release Tablet Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Felodipine Sustained-Release Tablet Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)
Table 59. Europe Felodipine Sustained-Release Tablet Sales by Type (2023-2028) & (K Units)
Table 60. Europe Felodipine Sustained-Release Tablet Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Felodipine Sustained-Release Tablet Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)
Table 63. Europe Felodipine Sustained-Release Tablet Sales by Application (2023-2028) & (K Units)
Table 64. Europe Felodipine Sustained-Release Tablet Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Felodipine Sustained-Release Tablet Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Felodipine Sustained-Release Tablet Sales by Country (2017-2022) & (K Units)
Table 67. Europe Felodipine Sustained-Release Tablet Sales by Country (2023-2028) & (K Units)
Table 68. Europe Felodipine Sustained-Release Tablet Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Felodipine Sustained-Release Tablet Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Felodipine Sustained-Release Tablet Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Felodipine Sustained-Release Tablet Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Felodipine Sustained-Release Tablet Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Felodipine Sustained-Release Tablet Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Felodipine Sustained-Release Tablet Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Felodipine Sustained-Release Tablet Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Felodipine Sustained-Release Tablet Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Felodipine Sustained-Release Tablet Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Felodipine Sustained-Release Tablet Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Felodipine Sustained-Release Tablet Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Felodipine Sustained-Release Tablet Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Felodipine Sustained-Release Tablet Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Felodipine Sustained-Release Tablet Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Felodipine Sustained-Release Tablet Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Felodipine Sustained-Release Tablet Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Felodipine Sustained-Release Tablet Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Felodipine Sustained-Release Tablet Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Felodipine Sustained-Release Tablet Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Felodipine Sustained-Release Tablet Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Felodipine Sustained-Release Tablet Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Felodipine Sustained-Release Tablet Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Felodipine Sustained-Release Tablet Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Felodipine Sustained-Release Tablet Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Felodipine Sustained-Release Tablet Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Country (2023-2028) & (US$ Million)
Table 106. Astrazeneca Corporation Information
Table 107. Astrazeneca Description and Major Businesses
Table 108. Astrazeneca Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. Astrazeneca Felodipine Sustained-Release Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Astrazeneca Recent Developments
Table 111. NanJing Easeheal Phaemaecutical Corporation Information
Table 112. NanJing Easeheal Phaemaecutical Description and Major Businesses
Table 113. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. NanJing Easeheal Phaemaecutical Recent Developments
Table 116. SHANXI KANGBO BIOLOGICAL PRODUCT Corporation Information
Table 117. SHANXI KANGBO BIOLOGICAL PRODUCT Description and Major Businesses
Table 118. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. SHANXI KANGBO BIOLOGICAL PRODUCT Recent Developments
Table 121. Lifeon Corporation Information
Table 122. Lifeon Description and Major Businesses
Table 123. Lifeon Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Lifeon Felodipine Sustained-Release Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Lifeon Recent Developments
Table 126. Changzhou Siyao Pharmaceutical Corporation Information
Table 127. Changzhou Siyao Pharmaceutical Description and Major Businesses
Table 128. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Changzhou Siyao Pharmaceutical Recent Developments
Table 131. Mylan Corporation Information
Table 132. Mylan Description and Major Businesses
Table 133. Mylan Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. Mylan Felodipine Sustained-Release Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Mylan Recent Developments
Table 136. Sandoz Corporation Information
Table 137. Sandoz Description and Major Businesses
Table 138. Sandoz Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Sandoz Felodipine Sustained-Release Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Sandoz Recent Developments
Table 141. Key Raw Materials Lists
Table 142. Raw Materials Key Suppliers Lists
Table 143. Felodipine Sustained-Release Tablet Distributors List
Table 144. Felodipine Sustained-Release Tablet Customers List
Table 145. Felodipine Sustained-Release Tablet Market Trends
Table 146. Felodipine Sustained-Release Tablet Market Drivers
Table 147. Felodipine Sustained-Release Tablet Market Challenges
Table 148. Felodipine Sustained-Release Tablet Market Restraints
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Felodipine Sustained-Release Tablet Product Picture
Figure 3. Global Felodipine Sustained-Release Tablet Market Share by Type in 2021 & 2028
Figure 3. 2.5mg Per Tablet Product Picture
Figure 4. 5mg Per Tablet Product Picture
Figure 5. Others Product Picture
Figure 6. Global Felodipine Sustained-Release Tablet Market Share by Application in 2021 & 2028
Figure 7. Treat High Blood Pressure
Figure 8. Relieve Angina
Figure 9. Others
Figure 10. Felodipine Sustained-Release Tablet Report Years Considered
Figure 11. Global Felodipine Sustained-Release Tablet Sales 2017-2028 (K Units)
Figure 12. Global Felodipine Sustained-Release Tablet Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Felodipine Sustained-Release Tablet Revenue 2017-2028 (US$ Million)
Figure 14. Global Felodipine Sustained-Release Tablet Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Felodipine Sustained-Release Tablet Sales Market Share by Region (2017-2022)
Figure 16. Global Felodipine Sustained-Release Tablet Sales Market Share by Region (2023-2028)
Figure 17. North America Felodipine Sustained-Release Tablet Sales YoY (2017-2028) & (K Units)
Figure 18. North America Felodipine Sustained-Release Tablet Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Felodipine Sustained-Release Tablet Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Felodipine Sustained-Release Tablet Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Felodipine Sustained-Release Tablet Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Felodipine Sustained-Release Tablet Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Felodipine Sustained-Release Tablet Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Felodipine Sustained-Release Tablet Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Felodipine Sustained-Release Tablet Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Felodipine Sustained-Release Tablet Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Felodipine Sustained-Release Tablet Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Felodipine Sustained-Release Tablet in the World: Market Share by Felodipine Sustained-Release Tablet Revenue in 2021
Figure 29. Global Felodipine Sustained-Release Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2028)
Figure 31. Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2017-2028)
Figure 32. Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2028)
Figure 33. Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2017-2028)
Figure 34. North America Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2028)
Figure 35. North America Felodipine Sustained-Release Tablet Revenue Market Share by Type (2017-2028)
Figure 36. North America Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2028)
Figure 37. North America Felodipine Sustained-Release Tablet Revenue Market Share by Application (2017-2028)
Figure 38. North America Felodipine Sustained-Release Tablet Sales Share by Country (2017-2028)
Figure 39. North America Felodipine Sustained-Release Tablet Revenue Share by Country (2017-2028)
Figure 40. United States Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2028)
Figure 43. Europe Felodipine Sustained-Release Tablet Revenue Market Share by Type (2017-2028)
Figure 44. Europe Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2028)
Figure 45. Europe Felodipine Sustained-Release Tablet Revenue Market Share by Application (2017-2028)
Figure 46. Europe Felodipine Sustained-Release Tablet Sales Share by Country (2017-2028)
Figure 47. Europe Felodipine Sustained-Release Tablet Revenue Share by Country (2017-2028)
Figure 48. Germany Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
Figure 49. France Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Felodipine Sustained-Release Tablet Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Felodipine Sustained-Release Tablet Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Felodipine Sustained-Release Tablet Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Felodipine Sustained-Release Tablet Revenue Share by Region (2017-2028)
Figure 59. China Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
Figure 62. India Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2028)
Figure 69. Latin America Felodipine Sustained-Release Tablet Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2028)
Figure 71. Latin America Felodipine Sustained-Release Tablet Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Felodipine Sustained-Release Tablet Sales Share by Country (2017-2028)
Figure 73. Latin America Felodipine Sustained-Release Tablet Revenue Share by Country (2017-2028)
Figure 74. Mexico Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Felodipine Sustained-Release Tablet Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Felodipine Sustained-Release Tablet Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Felodipine Sustained-Release Tablet Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Felodipine Sustained-Release Tablet Revenue Share by Country (2017-2028)
Figure 83. Turkey Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
Figure 86. Felodipine Sustained-Release Tablet Value Chain
Figure 87. Felodipine Sustained-Release Tablet Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Industry Market Size
